KLF4 and breast cancer: In other cancers, high expression of KLF4 was associated with increased OS in BC (HR =0.49, 95% CI: 0.33–0.72) (Fig. 5A) and head and neck tumours (HR =0.41, 95% CI: 0.23–0.75) (Fig. 5B).